ADMS

Adamas Pharmaceuticals, Inc.

ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

86 hedge funds and large institutions have $74.2M invested in Adamas Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New

Increased

Maintained

Reduced

Closed

2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2

Holders

Holders Change

Holders Change %

+11.69%

% of All Funds

1.89%

Holding in Top 10

–

Holding in Top 10 Change

-2

Holding in Top 10 Change %

-100%

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$656K

Puts

$581K

Net Calls

+$75K

Net Calls Change

-$26K

Top Buyers

1	Ameriprise Minneapolis, Minnesota	$5.21M
2	OAM Oxford Asset Management Oxford, United Kingdom	$955K
3	Renaissance Technologies New York	$632K
4	BG Bellevue Group Kuesnacht, Switzerland	$593K
5	Nuveen Asset Management Chicago, Illinois	$1.08M

Top Sellers

1	AC Armistice Capital New York	$2.74M
2	SCM Stonepine Capital Management Bend, Oregon	$3.84M
3	BC Broadfin Capital New York	$0
4	Millennium Management New York	$0
5	FI Fosun International Hong Kong, China	$0

#	Name	Holding	Trade Value	Shares Change	Shares Change %
26	BG 26 Bellevue Group Kuesnacht, Switzerland	$593K	+$593K	+116,000	New
27	BCM 27 Bridgeway Capital Management Houston, Texas	$588K	–	–	–
28	28 Bank of New York Mellon New York	$422K	-$10.3K	-2,006	-2%
29	29 Jacobs Levy Equity Management Florham Park, New Jersey	$402K	+$402K	+78,600	New
30	WVP 30 Worth Venture Partners Fort Lee, New Jersey	$396K	-$53.9K	-10,524	-12%
31	31 Wells Fargo San Francisco, California	$375K	+$260K	+50,858	+227%
32	32 D.E. Shaw & Co New York	$367K	+$367K	+71,724	New
33	BGIM 33 Brandywine Global Investment Management Philadelphia, Pennsylvania	$345K	-$75.2K	-14,655	-18%
34	DS 34 Dudley & Shanley Palm Beach, Florida	$345K	–	–	–
35	35 Susquehanna International Group Bala Cynwyd, Pennsylvania	$311K	-$195K	-38,177	-39%
36	36 T. Rowe Price Associates Baltimore, Maryland	$301K	+$669	+131	+0.2%
37	37 Two Sigma Investments New York	$298K	+$156K	+30,511	+110%
38	PP 38 PDT Partners New York	$272K	-$128K	-25,000	-32%
39	39 Charles Schwab San Francisco, California	$241K	–	–	–
40	40 AllianceBernstein Nashville, Tennessee	$218K	-$35.7K	-7,000	-14%
41	41 Jane Street New York	$199K	+$199K	+38,944	New
42	42 RhumbLine Advisers Boston, Massachusetts	$190K	+$15.2K	+2,974	+9%
43	43 SG Americas Securities New York	$188K	+$188K	+36,714	New
44	44 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$178K	–	–	–
45	45 State of Wisconsin Investment Board Madison, Wisconsin	$175K	+$20.5K	+4,000	+13%
46	46 Citadel Advisors Miami, Florida	$167K	-$20.4K	-3,991	-11%
47	BFM 47 Boothbay Fund Management New York	$159K	+$159K	+31,000	New
48	PAM 48 Panagora Asset Management Boston, Massachusetts	$152K	+$152K	+29,800	New
49	JG 49 Jefferies Group New York	$139K	+$139K	+27,258	New
50	PPA 50 Parametric Portfolio Associates Seattle, Washington	$111K	-$31.3K	-6,146	-22%

Adamas Pharmaceuticals, Inc. ADMS

Top Buyers

Top Sellers

Adamas Pharmaceuticals, Inc.

ADMS